388610 — Gfc Life Science Co Cashflow Statement
0.000.00%
Consumer DefensivesHighly SpeculativeSmall Cap
- KR₩117bn
- KR₩124bn
- KR₩17bn
Annual cashflow statement for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
Standards: | KAS | KAS | KAS | KAS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 1,617 | 327 | 1,437 | -5,947 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | -197 | 145 | -862 | 7,629 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -1,383 | -299 | 173 | -263 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 941 | 1,125 | 1,703 | 3,003 |
Capital Expenditures | -651 | -832 | -343 | -3,011 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 3,628 | -469 | 279 | 347 |
Sale of Business | ||||
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Sale of Intangible Assets | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | 2,977 | -1,301 | -64.3 | -2,664 |
Financing Cash Flow Items | — | — | -70 | 0 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -2,874 | -385 | -781 | -284 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 1,044 | -561 | 858 | 54.7 |